A new trading day began on Friday, with Verrica Pharmaceuticals Inc (NASDAQ: VRCA) stock price down -4.60% from the previous day of trading, before settling in for the closing price of $7.61. VRCA’s price has ranged from $3.28 to $9.82 over the past 52 weeks.
Annual sales at Healthcare sector company slipped by -5.46% over the past five years. Meanwhile, its annual earnings per share averaged 92.66%. With a float of $1.35 million, this company’s outstanding shares have now reached $9.49 million.
Verrica Pharmaceuticals Inc (VRCA) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Verrica Pharmaceuticals Inc is 91.54%, while institutional ownership is 19.87%. The most recent insider transaction that took place on Nov 25 ’25, was worth 10,000. In this transaction CMO of this company bought 2,357 shares at a rate of $4.24, taking the stock ownership to the 2,357 shares. Before that another transaction happened on Nov 25 ’25, when Company’s Interim CFO bought 3,536 for $4.24, making the entire transaction worth $15,001. This insider now owns 8,962 shares in total.
Verrica Pharmaceuticals Inc (VRCA) Latest Financial update
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -2.01 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.5 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 92.66% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 57.83% during the next five years compared to -5.46% drop over the previous five years of trading.
Verrica Pharmaceuticals Inc (NASDAQ: VRCA) Trading Performance Indicators
Here are Verrica Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.11. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.77.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.44, a number that is poised to hit -0.73 in the next quarter and is forecasted to reach -1.60 in one year’s time.
